Glenn Gregory M's Form 4 filing
Novavax Inc (NVAX) · filed Sep 1, 2021
- Accession no.
- 0001209191-21-054286
- Filed
- Sep 1, 2021
- Trade date
- Aug 31, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $332.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glenn Gregory MCIK 0001342823 | Officer (President, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2021 | Common Stock | SSaleDisposed | −53 | $234.64 | −$12,435.92 | 5,394 | Direct | |
| Aug 31, 2021 | Common Stock | SSaleDisposed | −108 | $237.14 | −$25,611.12 | 5,286 | Direct | |
| Aug 31, 2021 | Common Stock | SSaleDisposed | −320 | $238.72 | −$76,390.4 | 4,966 | Direct | |
| Aug 31, 2021 | Common Stock | SSaleDisposed | −359 | $239.66 | −$86,037.94 | 4,607 | Direct | |
| Aug 31, 2021 | Common Stock | SSaleDisposed | −175 | $240.58 | −$42,101.5 | 4,432 | Direct | |
| Aug 31, 2021 | Common Stock | SSaleDisposed | −209 | $241.59 | −$50,492.31 | 4,223 | Direct | |
| Aug 31, 2021 | Common Stock | SSaleDisposed | −100 | $242.63 | −$24,263 | 4,123 | Direct | |
| Aug 31, 2021 | Common Stock | SSaleDisposed | −62 | $244.03 | −$15,129.86 | 4,061 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.